By constructing a CRC mouse xenograft model, harboring KRAS mutant, it was found that the chromatin remodeling protein (INO80C) acts as an inhibitory factor of KRAS mutant CRC [64]. This evidence concerns the gene KRAS and colorectal carcinoma.